Prediabetes Screening and Treatment in Diabetes Prevention: The Impact of Physician Attitudes

References

1. 1.↵
   American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2016;39(Suppl 1):S13–22.

   OpenUrlFREE Full Text
2. 2.↵
   American Diabetes Association. Prevention or delay of type 2 diabetes. Diabetes Care 2015;38(Suppl 1):S31–2.

   OpenUrlFREE Full Text
3. 3.↵
   U.S. Preventive Services Task Force. Abnormal blood glucose and type 2 diabetes mellitus: screening. October 2015. Available from: http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/screening-for-abnormal-blood-glucose-and-type-2-diabetes. Accessed April 2016.
4. 4.↵
   1. Tabak AG,
   2. Herder C,
   3. Rathmann W,
   4. Brunner EJ,
   5. Kivimaki M

   . Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279–90.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Bullard KM,
   2. Saydah SH,
   3. Imperatore G,
   4. et al

   . Secular changes in U.S. prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999–2010. Diabetes Care 2013;36:2286–93.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Mainous AG 3rd.,
   2. Tanner RJ,
   3. Baker R,
   4. Zayas CE,
   5. Harle CA

   . Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open 2014;4:e005002.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Menke A,
   2. Casagrande S,
   3. Geiss L,
   4. Cowie CC

   . Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA 2015;314:1021–9.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Selph S,
   2. Dana T,
   3. Blazina I,
   4. Bougatsos C,
   5. Patel H,
   6. Chou R

   . Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2015;162:765–76.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Dunkley AJ,
   2. Bodicoat DH,
   3. Greaves CJ,
   4. et al

   . Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 2014;37:922–33.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    Centers for Disease Control and Prevention (CDC). Awareness of prediabetes–United States, 2005–2010. MMWR Morb Mortal Wkly Rep 2013;62:209–12.

    OpenUrlPubMed
11. 11.↵
    1. Mainous AG 3rd.,
    2. Tanner RJ,
    3. Baker R

    . Prediabetes diagnosis and treatment in primary care. J Am Board Fam Med 2016;29:283–5.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Treadwell J,
    2. McCartney M

    . Overdiagnosis and overtreatment: generalists—it's time for a grassroots revolution. Br J Gen Pract 2016;66:116–7.

    OpenUrlFREE Full Text
13. 13.↵
    1. Yudkin JS,
    2. Montori VM

    . The epidemic of pre-diabetes: the medicine and the politics. BMJ 2014;349:g4485.

    OpenUrlFREE Full Text
14. 14.↵
    U.S. Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148:846–54.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35 (supp 1):S64–S71.

    OpenUrlFREE Full Text
16. 16.↵
    1. Dall TM,
    2. Narayan KM,
    3. Gillespie KB,
    4. et al

    . Detecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelines. Popul Health Metr 2014;12:12.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Casagrande SS,
    2. Cowie CC,
    3. Fradkin JE

    . Utility of the U.S. Preventive Services Task Force criteria for diabetes screening. Am J Prev Med 2013;45:167–74.

    OpenUrl
18. 18.↵
    1. Knowler WC,
    2. Fowler SE,
    3. Hamman RF,
    4. et al

    Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, et al. 10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677–86.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Lin TL,
    2. Williams T,
    3. He J,
    4. et al

    . Rates of complete diagnostic testing for patients with acute myeloid leukemia. Cancer Med 2015;4:519–22.

    OpenUrl